Contract Award: HHS FDA CDER OCP analysis-platform iPortal development and maintenance

This 8(a) joint venture, which includes an award-winning Full Spectrum Digital Transformation company and 2024 Elev8 GovCon Honoree, won a 3-year contract in support of the Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Translational Sciences.

Aneon Brillient, LLC is an SBA-approved 8(a) joint venture that includes Aneon Federal and Brillient.

Awardee Name: ANEON BRILLIENT, LLC
Unique Entity ID: MS8HMAY331Q5
Total Contract Value: $1,121,468.31
Action Obligation: $362,821.29
Department Name: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Funding Agency: FOOD AND DRUG ADMINISTRATION
Funding Office: FDA OFFICE OF ACQ GRANT SVCS
Description: Direct 8(a) award of a 3-year, FFP-type Purchase Order to expand development and maintenance of OCP analysis-platform iPortal for the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Translational Sciences
Number of Bidders: 1
Award ID: 75F40124P00138
RFP ID: 75F40124Q00192
Set Aside Used: 8(a) Sole Source
Last Modified Date: 2024-05-07

More here.

🔊 Listen to Story